Related references
Note: Only part of the references are listed.Induction of senescence-associated secretory phenotype underlies the therapeutic efficacy of PRC2 inhibition in cancer
Liping Chu et al.
CELL DEATH & DISEASE (2022)
Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies
Ying Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Harnessing the cyclization strategy for new drug discovery
Kai Tang et al.
ACTA PHARMACEUTICA SINICA B (2022)
JARID2 and AEBP2 regulate PRC2 in the presence of H2AK119ub1 and other histone modifications
Vignesh Kasinath et al.
SCIENCE (2021)
Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
Rohan Kalyan Rej et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin
Siming Chen et al.
MOLECULAR CELL (2020)
EZH2: a novel target for cancer treatment
Ran Duan et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development
Rohan Kalyan Rej et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway
Jinghui Liang et al.
CELL DEATH & DISEASE (2020)
Small Molecule Approaches for Targeting the Polycomb Repressive Complex 2 (PRC2) in Cancer
M. Cynthia Martin et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
EED-Targeted PROTACs Degrade EED, EZH2, and SUZ12 in the PRC2 Complex
Jessie Hao-Ru Hsu et al.
CELL CHEMICAL BIOLOGY (2020)
Degradation of Polycomb Repressive Complex 2 with an EED-Targeted Bivalent Chemical Degrader
Frances Potjewyd et al.
CELL CHEMICAL BIOLOGY (2020)
Emerging roles of allosteric modulators in the regulation of protein-protein interactions (PPIs): A new paradigm for PPI drug discovery
Duan Ni et al.
MEDICINAL RESEARCH REVIEWS (2019)
Live-cell imaging reveals the dynamics of PRC2 and recruitment to chromatin by SUZ12-associated subunits
Daniel T. Youmans et al.
GENES & DEVELOPMENT (2018)
Unique Structural Platforms of Suz12 Dictate Distinct Classes of PRC2 for Chromatin Binding
Siming Chen et al.
MOLECULAR CELL (2018)
Structures of human PRC2 with its cofactors AEBP2 and JARID2
Vignesh Kasinath et al.
SCIENCE (2018)
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy
Ying Huang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structure-Guided Design of EED Binders Allosterically Inhibiting the Epigenetic Polycomb Repressive Complex 2 (PRC2) Methyltransferase
Andreas Lingel et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED
Wei Qi et al.
NATURE CHEMICAL BIOLOGY (2017)
The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex
Yupeng He et al.
NATURE CHEMICAL BIOLOGY (2017)
Development of secondary mutations in wild-type and mutant EZH2 alleles cooperates to confer resistance to EZH2 inhibitors
V. Gibaja et al.
ONCOGENE (2016)
PRC2 mediated H3K27 methylations in cellular identity and cancer
Eric Conway et al.
CURRENT OPINION IN CELL BIOLOGY (2015)
Structural basis of histone H3K27 trimethylation by an active polycomb repressive complex 2
Lianying Jiao et al.
SCIENCE (2015)
Transcriptional regulation by Polycomb group proteins
Luciano Di Croce et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)
Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay
Daniel Martinez Molina et al.
SCIENCE (2013)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Software News and Update AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading
Oleg Trott et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas
Christopher J. Sneeringer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Label-Free Detection of Biomolecular Interactions Using BioLayer Interferometry for Kinetic Characterization
Joy Concepcion et al.
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING (2009)
Role of the polycomb protein EED in the propagation of repressive histone marks
Raphael Margueron et al.
NATURE (2009)
Mechanisms of Polycomb gene silencing: knowns and unknowns
Jeffrey A. Simon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
EZH1 Mediates Methylation on Histone H3 Lysine 27 and Complements EZH2 in Maintaining Stem Cell Identity and Executing Pluripotency
Xiaohua Shen et al.
MOLECULAR CELL (2008)
A model for transmission of the H3K27me3 epigenetic mark
Klaus H. Hansen et al.
NATURE CELL BIOLOGY (2008)
Polycomb complexes repress developmental regulators in murine embryonic stem cells
LA Boyer et al.
NATURE (2006)
MSI1-like proteins: an escort service for chromatin assembly and remodeling complexes
L Hennig et al.
TRENDS IN CELL BIOLOGY (2005)
The murine polycomb group protein Eed is required for global histone H3 lysine-27 methylation
ND Montgomery et al.
CURRENT BIOLOGY (2005)
SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex
R Cao et al.
MOLECULAR CELL (2004)
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27
A Kirmizis et al.
GENES & DEVELOPMENT (2004)
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
D Pasini et al.
EMBO JOURNAL (2004)
Share Paper
